MEM.AX

Memphasys Limited MEM.AX

MEM.AX
Memphasys Limited BGT.AX
Bio-Gene Technology Limited IXC.AX
Invex Therapeutics Ltd CHM.AX
Chimeric Therapeutics Limited HIQ.AX
HITIQ Limited PER.AX
Percheron Therapeutics Limited CAN.AX
Cann Group Limited BIT.AX
Biotron Limited IVX.AX
Invion Limited ACR.AX
Acrux Limited

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode MEM.AX BGT.AX IXC.AX CHM.AX HIQ.AX PER.AX CAN.AX BIT.AX IVX.AX ACR.AX
6M -40.00 % 20.00 % 50.00 % -25.00 % -33.33 % -18.18 % -12.50 % 33.33 % -7.00 % -36.36 %
YTD -70.00 % -30.23 % 50.00 % -57.14 % -58.33 % 12.50 % -63.16 % -74.60 % -65.81 % -57.58 %
1Y -62.50 % -47.37 % 22.09 % -66.67 % -13.04 % -89.29 % -65.00 % -80.95 % -53.50 % -74.07 %
3Y -82.60 % -77.78 % -82.79 % -96.55 % -39.46 % -84.75 % -94.48 % -89.74 % -53.50 % -83.53 %
5Y -97.26 % -81.25 % -88.95 % -98.94 % -87.63 % -84.75 % -96.13 % -94.87 % -53.50 % -92.22 %
10Y -99.04 % -85.00 % -90.28 % -98.94 % -87.63 % -84.75 % -97.69 % -90.26 % -53.50 % -97.93 %
Depuis le début -99.94 % -85.00 % -90.28 % -98.94 % -87.63 % -84.75 % -97.69 % -98.94 % -53.50 % -98.60 %

Dividende

Invex Therapeutics Ltd

Acrux Limited